Dashboard
Manage Tickers

TARS


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

guggenheim-maintains-buy-on-tarsus-pharmaceuticals-raises-price-target-to-87
Guggenheim Maintains Buy on Tarsus Pharmac...
11/05/2025 15:04:29

Guggenheim analyst Eddie Hickman maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and raises the price target from ...

tarsus-pharmaceuticals-q3-eps-030-beats-038-estimate-sales-118697m-beat-115222m-estimate
Tarsus Pharmaceuticals Q3 EPS $(0.30) Beat...
11/04/2025 21:06:03

Tarsus Pharmaceuticals (NASDAQ:TARS) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate o...

earnings-scheduled-for-november-4-2025
Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

hc-wainwright--co-maintains-buy-on-tarsus-pharmaceuticals-raises-price-target-to-88
HC Wainwright & Co. Maintains Buy on Tarsu...
10/20/2025 10:40:10

HC Wainwright & Co. analyst Matthew Caufield maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and raises the pr...

top-2-health-care-stocks-that-may-fall-off-a-cliff-in-august
Top 2 Health Care Stocks That May Fall Off...
08/20/2025 12:46:03

tarsus-pharmaceuticals-q2-eps-048-misses-039-estimate-sales-102660m-beat-95682m-estimate
Tarsus Pharmaceuticals Q2 EPS $(0.48) Miss...
08/06/2025 20:06:29

Tarsus Pharmaceuticals (NASDAQ:TARS) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate...

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

tarsus-pharmaceuticals-stock-a-deep-dive-into-analyst-perspectives-4-ratings
Tarsus Pharmaceuticals Stock: A Deep Dive ...
05/27/2025 13:01:06

hc-wainwright--co-assumes-tarsus-pharmaceuticals-at-buy-announces-price-target-of-72
HC Wainwright & Co. Assumes Tarsus Pharmac...
05/27/2025 10:34:36

HC Wainwright & Co. analyst Matthew Caufield assumes Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy rating and announce...

6-analysts-assess-tarsus-pharmaceuticals-what-you-need-to-know
6 Analysts Assess Tarsus Pharmaceuticals: ...
05/05/2025 22:00:35

elanco-animal-health-sells-xdemvy-royalties-to-blackstone-in-295-million-deal
Elanco Animal Health Sells Xdemvy Royaltie...
05/05/2025 20:40:36

Elanco sells U.S. Xdemvy royalties to Blackstone for $295 million, aiming to lower debt and cut interest costs while retaining ...

goldman-sachs-maintains-neutral-on-tarsus-pharmaceuticals-raises-price-target-to-51
Goldman Sachs Maintains Neutral on Tarsus ...
05/05/2025 15:07:38

Goldman Sachs analyst Andrea Tan maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Neutral and raises the price target f...

Core News & Articles
Elanco Monetizes XDEMVY Royalties in $295M...
05/05/2025 10:29:02

Elanco Animal Health Incorporated (NYSE:ELAN) today announced the sale of certain future tiered royalties and commercial milest...

guggenheim-maintains-buy-on-tarsus-pharmaceuticals-raises-price-target-to-84
Guggenheim Maintains Buy on Tarsus Pharmac...
05/02/2025 16:15:46

Guggenheim analyst Eddie Hickman maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and raises the price target from ...

tarsus-pharmaceuticals-q1-eps-064-beats-076-estimate-sales-7833m-beat-7247m-estimate
Tarsus Pharmaceuticals Q1 EPS $(0.64) Beat...
05/01/2025 20:10:55

Core News & Articles
Earnings Scheduled For May 1, 2025
05/01/2025 08:32:37

an-overview-of-tarsus-pharmaceuticalss-earnings
An Overview of Tarsus Pharmaceuticals's Ea...
04/30/2025 20:01:42

tarsus-to-present-several-scientific-abstracts-highlighting-the-global-prevalence-of-demodex-blepharitis-and-the-clinical-impact-of-xdemvy-at-the-ascrs-2025-annual-meeting
Tarsus To Present Several Scientific Abstr...
04/22/2025 12:33:38

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) will present four distinct data sets highlighting the global prevalence and real-wor...

reported-earlier-tarsus-pharmaceuticals-prices-upsized-125m-public-offering-at-4450-per-share-for-281m-shares
Reported Earlier, Tarsus Pharmaceuticals P...
03/13/2025 05:29:56

tarsus-announces-proposed-100m-public-offering-of-common-stock
Tarsus Announces Proposed $100M Public Off...
03/12/2025 20:15:16

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION